MAPT and Alzheimer disease: Since CDK5 is also activated in AD (Liu et al., 2016) and phosphorylates tau (Kimura et al., 2014), it is likely that decreased dynein in P301L cells might be an early adaptation mechanism to fine-tune the transport from being too robust in the retrograde direction.